Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
Barata P, Agarwal N, Nussenzveig R, Gerendash B, Jaeger E, Hatton W, Ledet E, Lewis B, Layton J, Babiker H, Bryce A, Garje R, Stein C, Kiedrowski L, Saylor P, Sartor O.
Barata P, et al.
J Immunother Cancer. 2020 Aug;8(2):e001065. doi: 10.1136/jitc-2020-001065.
J Immunother Cancer. 2020.
PMID: 32788235
Free PMC article.